THE ROLE OF ENDOTHELIAL DYSFUNCTION IN THE DEVELOPMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH ANKYLOSING SPONDYLARTHRITIS

Authors

  • S. I. Smiyan I. Horbachevsky Ternopil State Medical University
  • B. O. Koshak I. Horbachevsky Ternopil State Medical University
  • A. V. Bilukha I. Horbachevsky Ternopil State Medical University
  • D. O. Koshak I. Horbachevsky Ternopil State Medical University

DOI:

https://doi.org/10.11603/1681-2786.2018.2.9371

Keywords:

ankylosing spondylitis, arterial hypertension, endothelial dysfunction

Abstract

Purpose: to establish the role of endothelial dysfunction in the development of arterial hypertension in patients with ankylosing spondylarthritis.

Materials and Methods. A total of 110 patients with AS were examined with evaluation endothelium-dependent vasodilation (EDVD). All patients received antihypertensive therapy which did not change throughout all study.

Results. It was found that every third patient  suffered from hypertension, endothelial function disorders were detected in 71.8 % of patients. A large cohort of patients showed low levels of HDL and elevated levels of LDL.

At the same time, significant differences in disease activity and functional status were found in the group with hypertension.

Conclusions. We must assume that endothelial dysfunction, which occurs on the background of systemic inflammatory syndrome, is probably the main reason for the development of hypertension in patients with AS.

References

Altaany, Z., Moccia, F. & Munaron L. (2014). Hydrogen sulfide and endothelial dysfunction: relationship with nitric oxide. Curr. Med. Chem., 21 (32), 3646-3661.

Braun, J. (2007). Ankylosing spondylitis. Lancet, 369, 1379-1390.

Busse, R., Fleming, I., & Hecker, M. (1993). Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy. J. Cardiovasc. Pharmacol., 22, 31–36.

Celermajer, D.S., Sorensen, K.E., Gooch, V.M. (1992). Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, 1111-1115.

Chen, H.A., Chen, С.H., & Liao, H.T. (2012). Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J. Rheumatol., 39, 3-8.

Donald, J.A., Forgan, L.G., & Cameron, M.S. (2015). The evolution of nitric oxide signalling in vertebrate blood vessels. J. Comp. Physiol. B., 185 (2), 153-171.

Dzieża-Grudnik, A., Sulicka, J., & Strach, M. (2017). Arterial stiffness is not increased in patients with short duration rheumatoid arthritis and ankylosing spondylitis. Blood Press., 26 (2), 115-121.

Heeneman, S., & Daemen M.J. (2017). Cardiovascular risks in spondyloarthritides. Curr. Opin. Rheumatol., 19, 358-362.

Korkmaz, H., & Koç, M. (2008). Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension. Endothelium, 15 (3), 149-155.

Paulo, M., Banin, T.M., de Andrade, F.A., & Bendhack, L.M. (2014). Enhancing vascular relaxing effects of nitric oxide-donor ruthenium complexes. Future Med. Chem., 6 (7), 825-838.

Smith, J. A. (2015). Update on ankylosing spondylitis: current concepts in pathogenesis. Curr. Allergy Asthma Rep., 15 (1), 489.

Sokka, T., Abelson, B., & Pincus, T. (2008). Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol.,

(51), 356-361.

Van der Heijde, D., Ramiro, S., & Landewé, R. (2017). 2016 update of the ASAS -EULAR management recommendations for axial spondyloarthritis. Ann. Rheum. Dis., 76 (6), 978-991.

Published

2018-09-27

How to Cite

Smiyan, S. I., Koshak, B. O., Bilukha, A. V., & Koshak, D. O. (2018). THE ROLE OF ENDOTHELIAL DYSFUNCTION IN THE DEVELOPMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH ANKYLOSING SPONDYLARTHRITIS. Bulletin of Social Hygiene and Health Protection Organization of Ukraine, (2). https://doi.org/10.11603/1681-2786.2018.2.9371

Issue

Section

The science for health care practice